nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—CYP3A5—Teniposide—lymphatic system cancer	0.114	0.17	CbGbCtD
Itraconazole—CYP2E1—Mitoxantrone—lymphatic system cancer	0.103	0.153	CbGbCtD
Itraconazole—CYP3A7—Vincristine—lymphatic system cancer	0.0732	0.109	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0732	0.109	CbGbCtD
Itraconazole—CYP3A5—Vincristine—lymphatic system cancer	0.0549	0.082	CbGbCtD
Itraconazole—ABCB1—Mitoxantrone—lymphatic system cancer	0.0519	0.0776	CbGbCtD
Itraconazole—CYP3A4—Cytarabine—lymphatic system cancer	0.0451	0.0674	CbGbCtD
Itraconazole—CYP3A4—Teniposide—lymphatic system cancer	0.0445	0.0664	CbGbCtD
Itraconazole—ABCB1—Vincristine—lymphatic system cancer	0.0357	0.0534	CbGbCtD
Itraconazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0311	0.0465	CbGbCtD
Itraconazole—ABCB1—Methotrexate—lymphatic system cancer	0.0216	0.0323	CbGbCtD
Itraconazole—CYP3A4—Vincristine—lymphatic system cancer	0.0214	0.032	CbGbCtD
Itraconazole—Myalgia—Bleomycin—lymphatic system cancer	0.000517	0.00156	CcSEcCtD
Itraconazole—Alopecia—Vincristine—lymphatic system cancer	0.000513	0.00155	CcSEcCtD
Itraconazole—Back pain—Carmustine—lymphatic system cancer	0.000512	0.00155	CcSEcCtD
Itraconazole—Discomfort—Bleomycin—lymphatic system cancer	0.00051	0.00154	CcSEcCtD
Itraconazole—Mental disorder—Vincristine—lymphatic system cancer	0.000509	0.00154	CcSEcCtD
Itraconazole—Chills—Mitoxantrone—lymphatic system cancer	0.000507	0.00153	CcSEcCtD
Itraconazole—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000507	0.00153	CcSEcCtD
Itraconazole—Bladder pain—Methotrexate—lymphatic system cancer	0.000507	0.00153	CcSEcCtD
Itraconazole—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000505	0.00153	CcSEcCtD
Itraconazole—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000502	0.00152	CcSEcCtD
Itraconazole—Alopecia—Mitoxantrone—lymphatic system cancer	0.0005	0.00151	CcSEcCtD
Itraconazole—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000499	0.00151	CcSEcCtD
Itraconazole—Confusional state—Bleomycin—lymphatic system cancer	0.000499	0.00151	CcSEcCtD
Itraconazole—Vision blurred—Carmustine—lymphatic system cancer	0.000499	0.00151	CcSEcCtD
Itraconazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000498	0.0015	CcSEcCtD
Itraconazole—Tremor—Carmustine—lymphatic system cancer	0.000496	0.0015	CcSEcCtD
Itraconazole—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000495	0.0015	CcSEcCtD
Itraconazole—Oedema—Bleomycin—lymphatic system cancer	0.000495	0.0015	CcSEcCtD
Itraconazole—Infection—Bleomycin—lymphatic system cancer	0.000492	0.00149	CcSEcCtD
Itraconazole—Back pain—Vincristine—lymphatic system cancer	0.000489	0.00148	CcSEcCtD
Itraconazole—Vomiting—Teniposide—lymphatic system cancer	0.000489	0.00148	CcSEcCtD
Itraconazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000485	0.00147	CcSEcCtD
Itraconazole—Asthenia—Fludarabine—lymphatic system cancer	0.000485	0.00147	CcSEcCtD
Itraconazole—Rash—Teniposide—lymphatic system cancer	0.000484	0.00147	CcSEcCtD
Itraconazole—Dermatitis—Teniposide—lymphatic system cancer	0.000484	0.00146	CcSEcCtD
Itraconazole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000482	0.00146	CcSEcCtD
Itraconazole—Headache—Teniposide—lymphatic system cancer	0.000481	0.00146	CcSEcCtD
Itraconazole—Pruritus—Fludarabine—lymphatic system cancer	0.000478	0.00145	CcSEcCtD
Itraconazole—Back pain—Mitoxantrone—lymphatic system cancer	0.000476	0.00144	CcSEcCtD
Itraconazole—Leukopenia—Carmustine—lymphatic system cancer	0.000474	0.00143	CcSEcCtD
Itraconazole—Anorexia—Bleomycin—lymphatic system cancer	0.000472	0.00143	CcSEcCtD
Itraconazole—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000464	0.0014	CcSEcCtD
Itraconazole—Photosensitivity—Methotrexate—lymphatic system cancer	0.000464	0.0014	CcSEcCtD
Itraconazole—Hypotension—Bleomycin—lymphatic system cancer	0.000463	0.0014	CcSEcCtD
Itraconazole—Diarrhoea—Fludarabine—lymphatic system cancer	0.000462	0.0014	CcSEcCtD
Itraconazole—Hypertension—Carmustine—lymphatic system cancer	0.000457	0.00138	CcSEcCtD
Itraconazole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000457	0.00138	CcSEcCtD
Itraconazole—Nausea—Teniposide—lymphatic system cancer	0.000456	0.00138	CcSEcCtD
Itraconazole—Vertigo—Vincristine—lymphatic system cancer	0.000454	0.00137	CcSEcCtD
Itraconazole—Hepatic failure—Methotrexate—lymphatic system cancer	0.000453	0.00137	CcSEcCtD
Itraconazole—Leukopenia—Vincristine—lymphatic system cancer	0.000453	0.00137	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000451	0.00136	CcSEcCtD
Itraconazole—Chest pain—Carmustine—lymphatic system cancer	0.000451	0.00136	CcSEcCtD
Itraconazole—Myalgia—Carmustine—lymphatic system cancer	0.000451	0.00136	CcSEcCtD
Itraconazole—Anxiety—Carmustine—lymphatic system cancer	0.000449	0.00136	CcSEcCtD
Itraconazole—Paraesthesia—Bleomycin—lymphatic system cancer	0.000445	0.00134	CcSEcCtD
Itraconazole—Malaise—Mitoxantrone—lymphatic system cancer	0.000444	0.00134	CcSEcCtD
Itraconazole—Dyspnoea—Bleomycin—lymphatic system cancer	0.000441	0.00134	CcSEcCtD
Itraconazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000441	0.00133	CcSEcCtD
Itraconazole—Hypertension—Vincristine—lymphatic system cancer	0.000436	0.00132	CcSEcCtD
Itraconazole—Confusional state—Carmustine—lymphatic system cancer	0.000436	0.00132	CcSEcCtD
Itraconazole—Oedema—Carmustine—lymphatic system cancer	0.000432	0.00131	CcSEcCtD
Itraconazole—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000432	0.00131	CcSEcCtD
Itraconazole—Decreased appetite—Bleomycin—lymphatic system cancer	0.00043	0.0013	CcSEcCtD
Itraconazole—Myalgia—Vincristine—lymphatic system cancer	0.00043	0.0013	CcSEcCtD
Itraconazole—Visual disturbance—Methotrexate—lymphatic system cancer	0.00043	0.0013	CcSEcCtD
Itraconazole—Cough—Mitoxantrone—lymphatic system cancer	0.00043	0.0013	CcSEcCtD
Itraconazole—Infection—Carmustine—lymphatic system cancer	0.000429	0.0013	CcSEcCtD
Itraconazole—Vomiting—Fludarabine—lymphatic system cancer	0.000429	0.0013	CcSEcCtD
Itraconazole—Rash—Fludarabine—lymphatic system cancer	0.000426	0.00129	CcSEcCtD
Itraconazole—Dermatitis—Fludarabine—lymphatic system cancer	0.000425	0.00129	CcSEcCtD
Itraconazole—Hypertension—Mitoxantrone—lymphatic system cancer	0.000425	0.00129	CcSEcCtD
Itraconazole—Pain—Bleomycin—lymphatic system cancer	0.000423	0.00128	CcSEcCtD
Itraconazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000423	0.00128	CcSEcCtD
Itraconazole—Headache—Fludarabine—lymphatic system cancer	0.000423	0.00128	CcSEcCtD
Itraconazole—Tachycardia—Carmustine—lymphatic system cancer	0.000422	0.00128	CcSEcCtD
Itraconazole—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000421	0.00127	CcSEcCtD
Itraconazole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000419	0.00127	CcSEcCtD
Itraconazole—Chest pain—Mitoxantrone—lymphatic system cancer	0.000419	0.00127	CcSEcCtD
Itraconazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.000419	0.00127	CcSEcCtD
Itraconazole—Anxiety—Mitoxantrone—lymphatic system cancer	0.000418	0.00126	CcSEcCtD
Itraconazole—Discomfort—Mitoxantrone—lymphatic system cancer	0.000414	0.00125	CcSEcCtD
Itraconazole—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000413	0.00125	CcSEcCtD
Itraconazole—Oedema—Vincristine—lymphatic system cancer	0.000413	0.00125	CcSEcCtD
Itraconazole—Anorexia—Carmustine—lymphatic system cancer	0.000412	0.00125	CcSEcCtD
Itraconazole—Infection—Vincristine—lymphatic system cancer	0.00041	0.00124	CcSEcCtD
Itraconazole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000408	0.00123	CcSEcCtD
Itraconazole—Confusional state—Mitoxantrone—lymphatic system cancer	0.000405	0.00123	CcSEcCtD
Itraconazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.000405	0.00122	CcSEcCtD
Itraconazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000404	0.00122	CcSEcCtD
Itraconazole—Hypotension—Carmustine—lymphatic system cancer	0.000404	0.00122	CcSEcCtD
Itraconazole—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000402	0.00122	CcSEcCtD
Itraconazole—Oedema—Mitoxantrone—lymphatic system cancer	0.000402	0.00122	CcSEcCtD
Itraconazole—Nausea—Fludarabine—lymphatic system cancer	0.000401	0.00121	CcSEcCtD
Itraconazole—Infection—Mitoxantrone—lymphatic system cancer	0.000399	0.00121	CcSEcCtD
Itraconazole—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000399	0.00121	CcSEcCtD
Itraconazole—Shock—Mitoxantrone—lymphatic system cancer	0.000395	0.0012	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000394	0.00119	CcSEcCtD
Itraconazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000393	0.00119	CcSEcCtD
Itraconazole—Urticaria—Bleomycin—lymphatic system cancer	0.000393	0.00119	CcSEcCtD
Itraconazole—Anorexia—Vincristine—lymphatic system cancer	0.000393	0.00119	CcSEcCtD
Itraconazole—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000392	0.00119	CcSEcCtD
Itraconazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.000391	0.00118	CcSEcCtD
Itraconazole—Insomnia—Carmustine—lymphatic system cancer	0.000391	0.00118	CcSEcCtD
Itraconazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00039	0.00118	CcSEcCtD
Itraconazole—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000388	0.00117	CcSEcCtD
Itraconazole—Paraesthesia—Carmustine—lymphatic system cancer	0.000388	0.00117	CcSEcCtD
Itraconazole—Hypotension—Vincristine—lymphatic system cancer	0.000386	0.00117	CcSEcCtD
Itraconazole—Dyspnoea—Carmustine—lymphatic system cancer	0.000385	0.00117	CcSEcCtD
Itraconazole—Somnolence—Carmustine—lymphatic system cancer	0.000384	0.00116	CcSEcCtD
Itraconazole—Anorexia—Mitoxantrone—lymphatic system cancer	0.000383	0.00116	CcSEcCtD
Itraconazole—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000376	0.00114	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000376	0.00114	CcSEcCtD
Itraconazole—Decreased appetite—Carmustine—lymphatic system cancer	0.000376	0.00114	CcSEcCtD
Itraconazole—Hypotension—Mitoxantrone—lymphatic system cancer	0.000375	0.00114	CcSEcCtD
Itraconazole—Insomnia—Vincristine—lymphatic system cancer	0.000373	0.00113	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000373	0.00113	CcSEcCtD
Itraconazole—Paraesthesia—Vincristine—lymphatic system cancer	0.00037	0.00112	CcSEcCtD
Itraconazole—Pain—Carmustine—lymphatic system cancer	0.00037	0.00112	CcSEcCtD
Itraconazole—Constipation—Carmustine—lymphatic system cancer	0.00037	0.00112	CcSEcCtD
Itraconazole—Breast disorder—Methotrexate—lymphatic system cancer	0.000368	0.00111	CcSEcCtD
Itraconazole—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000367	0.00111	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000366	0.00111	CcSEcCtD
Itraconazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000365	0.0011	CcSEcCtD
Itraconazole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000361	0.00109	CcSEcCtD
Itraconazole—Decreased appetite—Vincristine—lymphatic system cancer	0.000359	0.00108	CcSEcCtD
Itraconazole—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000358	0.00108	CcSEcCtD
Itraconazole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000357	0.00108	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000356	0.00108	CcSEcCtD
Itraconazole—Feeling abnormal—Carmustine—lymphatic system cancer	0.000356	0.00108	CcSEcCtD
Itraconazole—Fatigue—Vincristine—lymphatic system cancer	0.000356	0.00108	CcSEcCtD
Itraconazole—Asthenia—Bleomycin—lymphatic system cancer	0.000355	0.00107	CcSEcCtD
Itraconazole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000354	0.00107	CcSEcCtD
Itraconazole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000353	0.00107	CcSEcCtD
Itraconazole—Pain—Vincristine—lymphatic system cancer	0.000353	0.00107	CcSEcCtD
Itraconazole—Constipation—Vincristine—lymphatic system cancer	0.000353	0.00107	CcSEcCtD
Itraconazole—Pruritus—Bleomycin—lymphatic system cancer	0.00035	0.00106	CcSEcCtD
Itraconazole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000349	0.00106	CcSEcCtD
Itraconazole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000346	0.00105	CcSEcCtD
Itraconazole—Pancreatitis—Methotrexate—lymphatic system cancer	0.000345	0.00104	CcSEcCtD
Itraconazole—Pain—Mitoxantrone—lymphatic system cancer	0.000344	0.00104	CcSEcCtD
Itraconazole—Constipation—Mitoxantrone—lymphatic system cancer	0.000344	0.00104	CcSEcCtD
Itraconazole—Body temperature increased—Carmustine—lymphatic system cancer	0.000342	0.00103	CcSEcCtD
Itraconazole—Abdominal pain—Carmustine—lymphatic system cancer	0.000342	0.00103	CcSEcCtD
Itraconazole—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000338	0.00102	CcSEcCtD
Itraconazole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000337	0.00102	CcSEcCtD
Itraconazole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000331	0.001	CcSEcCtD
Itraconazole—Neutropenia—Methotrexate—lymphatic system cancer	0.000329	0.000996	CcSEcCtD
Itraconazole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000329	0.000994	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000327	0.00099	CcSEcCtD
Itraconazole—Abdominal pain—Vincristine—lymphatic system cancer	0.000326	0.000986	CcSEcCtD
Itraconazole—Body temperature increased—Vincristine—lymphatic system cancer	0.000326	0.000986	CcSEcCtD
Itraconazole—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000324	0.000981	CcSEcCtD
Itraconazole—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000321	0.000972	CcSEcCtD
Itraconazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000319	0.000965	CcSEcCtD
Itraconazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000318	0.000963	CcSEcCtD
Itraconazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000318	0.000961	CcSEcCtD
Itraconazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000318	0.000961	CcSEcCtD
Itraconazole—Pneumonia—Methotrexate—lymphatic system cancer	0.000316	0.000955	CcSEcCtD
Itraconazole—Vomiting—Bleomycin—lymphatic system cancer	0.000315	0.000952	CcSEcCtD
Itraconazole—Drowsiness—Methotrexate—lymphatic system cancer	0.000314	0.000949	CcSEcCtD
Itraconazole—Infestation NOS—Methotrexate—lymphatic system cancer	0.000314	0.000949	CcSEcCtD
Itraconazole—Infestation—Methotrexate—lymphatic system cancer	0.000314	0.000949	CcSEcCtD
Itraconazole—Depression—Methotrexate—lymphatic system cancer	0.000313	0.000947	CcSEcCtD
Itraconazole—Rash—Bleomycin—lymphatic system cancer	0.000312	0.000944	CcSEcCtD
Itraconazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000312	0.000943	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000311	0.000941	CcSEcCtD
Itraconazole—Asthenia—Carmustine—lymphatic system cancer	0.00031	0.000938	CcSEcCtD
Itraconazole—Renal failure—Methotrexate—lymphatic system cancer	0.000309	0.000933	CcSEcCtD
Itraconazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000304	0.000919	CcSEcCtD
Itraconazole—Haematuria—Methotrexate—lymphatic system cancer	0.000299	0.000905	CcSEcCtD
Itraconazole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000297	0.000898	CcSEcCtD
Itraconazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000296	0.000895	CcSEcCtD
Itraconazole—Asthenia—Vincristine—lymphatic system cancer	0.000296	0.000895	CcSEcCtD
Itraconazole—Diarrhoea—Carmustine—lymphatic system cancer	0.000296	0.000894	CcSEcCtD
Itraconazole—Nausea—Bleomycin—lymphatic system cancer	0.000294	0.00089	CcSEcCtD
Itraconazole—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000293	0.000886	CcSEcCtD
Itraconazole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000288	0.000872	CcSEcCtD
Itraconazole—Dizziness—Carmustine—lymphatic system cancer	0.000286	0.000864	CcSEcCtD
Itraconazole—Diarrhoea—Vincristine—lymphatic system cancer	0.000282	0.000854	CcSEcCtD
Itraconazole—Hepatitis—Methotrexate—lymphatic system cancer	0.000282	0.000852	CcSEcCtD
Itraconazole—Pharyngitis—Methotrexate—lymphatic system cancer	0.00028	0.000846	CcSEcCtD
Itraconazole—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000278	0.000842	CcSEcCtD
Itraconazole—Urethral disorder—Methotrexate—lymphatic system cancer	0.000276	0.000835	CcSEcCtD
Itraconazole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000275	0.000832	CcSEcCtD
Itraconazole—Vomiting—Carmustine—lymphatic system cancer	0.000275	0.000831	CcSEcCtD
Itraconazole—Dizziness—Vincristine—lymphatic system cancer	0.000273	0.000825	CcSEcCtD
Itraconazole—Rash—Carmustine—lymphatic system cancer	0.000273	0.000824	CcSEcCtD
Itraconazole—Dermatitis—Carmustine—lymphatic system cancer	0.000272	0.000823	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—lymphatic system cancer	0.000272	0.000821	CcSEcCtD
Itraconazole—Headache—Carmustine—lymphatic system cancer	0.000271	0.000819	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000266	0.000806	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—lymphatic system cancer	0.000263	0.000796	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—lymphatic system cancer	0.000263	0.000795	CcSEcCtD
Itraconazole—Vomiting—Vincristine—lymphatic system cancer	0.000262	0.000793	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000262	0.000791	CcSEcCtD
Itraconazole—Rash—Vincristine—lymphatic system cancer	0.00026	0.000787	CcSEcCtD
Itraconazole—Dermatitis—Vincristine—lymphatic system cancer	0.00026	0.000786	CcSEcCtD
Itraconazole—Headache—Vincristine—lymphatic system cancer	0.000258	0.000782	CcSEcCtD
Itraconazole—Nausea—Carmustine—lymphatic system cancer	0.000257	0.000776	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—lymphatic system cancer	0.000256	0.000773	CcSEcCtD
Itraconazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000255	0.000773	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000255	0.00077	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000254	0.000768	CcSEcCtD
Itraconazole—Rash—Mitoxantrone—lymphatic system cancer	0.000253	0.000766	CcSEcCtD
Itraconazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000253	0.000766	CcSEcCtD
Itraconazole—Chills—Methotrexate—lymphatic system cancer	0.000253	0.000765	CcSEcCtD
Itraconazole—Headache—Mitoxantrone—lymphatic system cancer	0.000252	0.000761	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—lymphatic system cancer	0.000249	0.000753	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—lymphatic system cancer	0.000247	0.000747	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—lymphatic system cancer	0.000245	0.000742	CcSEcCtD
Itraconazole—Nausea—Vincristine—lymphatic system cancer	0.000245	0.000741	CcSEcCtD
Itraconazole—Dysgeusia—Methotrexate—lymphatic system cancer	0.00024	0.000727	CcSEcCtD
Itraconazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000239	0.000722	CcSEcCtD
Itraconazole—Back pain—Methotrexate—lymphatic system cancer	0.000237	0.000718	CcSEcCtD
Itraconazole—Vision blurred—Methotrexate—lymphatic system cancer	0.000231	0.000699	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000228	0.000688	CcSEcCtD
Itraconazole—Malaise—Methotrexate—lymphatic system cancer	0.000221	0.000669	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—lymphatic system cancer	0.00022	0.000667	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—lymphatic system cancer	0.00022	0.000664	CcSEcCtD
Itraconazole—Cough—Methotrexate—lymphatic system cancer	0.000214	0.000647	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—lymphatic system cancer	0.000209	0.000632	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—lymphatic system cancer	0.000209	0.000632	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—lymphatic system cancer	0.000209	0.000632	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000207	0.000627	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—lymphatic system cancer	0.000206	0.000624	CcSEcCtD
Itraconazole—Confusional state—Methotrexate—lymphatic system cancer	0.000202	0.000611	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.0002	0.000606	CcSEcCtD
Itraconazole—Infection—Methotrexate—lymphatic system cancer	0.000199	0.000602	CcSEcCtD
Itraconazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000196	0.000594	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000196	0.000593	CcSEcCtD
Itraconazole—Skin disorder—Methotrexate—lymphatic system cancer	0.000194	0.000588	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000194	0.000585	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—lymphatic system cancer	0.000191	0.000577	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—lymphatic system cancer	0.000187	0.000566	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000182	0.000552	CcSEcCtD
Itraconazole—Insomnia—Methotrexate—lymphatic system cancer	0.000181	0.000548	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—lymphatic system cancer	0.00018	0.000544	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—lymphatic system cancer	0.000178	0.00054	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—lymphatic system cancer	0.000178	0.000538	CcSEcCtD
Itraconazole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000176	0.000533	CcSEcCtD
Itraconazole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000174	0.000526	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000173	0.000523	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—lymphatic system cancer	0.000173	0.000522	CcSEcCtD
Itraconazole—Pain—Methotrexate—lymphatic system cancer	0.000171	0.000518	CcSEcCtD
Itraconazole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000165	0.000499	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000164	0.000495	CcSEcCtD
Itraconazole—Urticaria—Methotrexate—lymphatic system cancer	0.000159	0.000481	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.000158	0.000479	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000158	0.000479	CcSEcCtD
Itraconazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000147	0.000446	CcSEcCtD
Itraconazole—Asthenia—Methotrexate—lymphatic system cancer	0.000144	0.000434	CcSEcCtD
Itraconazole—Pruritus—Methotrexate—lymphatic system cancer	0.000142	0.000428	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000137	0.000414	CcSEcCtD
Itraconazole—Dizziness—Methotrexate—lymphatic system cancer	0.000132	0.0004	CcSEcCtD
Itraconazole—Vomiting—Methotrexate—lymphatic system cancer	0.000127	0.000385	CcSEcCtD
Itraconazole—Rash—Methotrexate—lymphatic system cancer	0.000126	0.000382	CcSEcCtD
Itraconazole—Dermatitis—Methotrexate—lymphatic system cancer	0.000126	0.000381	CcSEcCtD
Itraconazole—Headache—Methotrexate—lymphatic system cancer	0.000125	0.000379	CcSEcCtD
Itraconazole—Nausea—Methotrexate—lymphatic system cancer	0.000119	0.00036	CcSEcCtD
